TULVEGIO RIVOCERANIB Trademark

Trademark Overview

On Tuesday, September 17, 2019, a trademark application was filed for TULVEGIO RIVOCERANIB with the United States Patent and Trademark Office. The USPTO has given the TULVEGIO RIVOCERANIB trademark a serial number of 88620374. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 23, 2024. This trademark is owned by Elevar Therapeutics, Inc.. The TULVEGIO RIVOCERANIB trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer

Development of therapeutics for the treatment of cancer containing rivoceranib
tulvegio rivoceranib

General Information

Serial Number88620374
Word MarkTULVEGIO RIVOCERANIB
Filing DateTuesday, September 17, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 22, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".
Goods and ServicesPharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "TULVEGIO RIVOCERANIB" has no meaning in a foreign language.
NOT AVAILABLE"RIVOCERANIB"
Goods and ServicesDevelopment of therapeutics for the treatment of cancer containing rivoceranib

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameElevar Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121
Party NameElevar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121

Trademark Events

Event DateEvent Description
Friday, September 20, 2019NEW APPLICATION ENTERED
Tuesday, September 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 25, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 12, 2019ASSIGNED TO EXAMINER
Saturday, November 16, 2019NON-FINAL ACTION WRITTEN
Saturday, November 16, 2019NON-FINAL ACTION E-MAILED
Saturday, November 16, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 12, 2020NON-FINAL ACTION WRITTEN
Friday, June 12, 2020NON-FINAL ACTION E-MAILED
Friday, June 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 14, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 14, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 14, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 29, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, January 4, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, January 8, 2021NON-FINAL ACTION WRITTEN
Friday, January 8, 2021NON-FINAL ACTION E-MAILED
Friday, January 8, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 17, 2021ASSIGNED TO LIE
Wednesday, May 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 19, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 19, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 19, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, May 19, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 19, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, May 19, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 22, 2021PUBLISHED FOR OPPOSITION
Tuesday, June 22, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 17, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 17, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 17, 2022SOU EXTENSION 1 FILED
Thursday, February 17, 2022SOU EXTENSION 1 GRANTED
Saturday, February 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 1, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 1, 2022SOU EXTENSION 2 FILED
Monday, August 1, 2022SOU EXTENSION 2 GRANTED
Wednesday, August 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023SOU EXTENSION 3 FILED
Wednesday, February 15, 2023SOU EXTENSION 3 GRANTED
Friday, February 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 15, 2023SOU EXTENSION 4 FILED
Monday, August 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 21, 2023SOU EXTENSION 4 GRANTED
Tuesday, August 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, February 13, 2024SOU EXTENSION 5 FILED
Tuesday, February 13, 2024SOU EXTENSION 5 GRANTED
Wednesday, February 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 23, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 23, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

rivoceranib tulvegio treatment cancer containing therapeutics development preparations substances pharmaceutical